Back to Search
QUANG LE, MD
MD
Legal Medicine
NPI: 1609179076Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03.
PMID 19667273·J Clin Oncol·2009
4-observational
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.
PMID 19364954·J Clin Oncol·2009
3-trial
Cost-effectiveness analysis of lapatinib in HER-2-positive advanced breast cancer.
PMID 19117341·Cancer·2009
8-other
Integrating biologically targeted therapy in head and neck squamous cell carcinomas.
PMID 19028346·Semin Radiat Oncol·2009
6-review
In vivo 1H magnetic resonance spectroscopy of lactate in patients with stage IV head and neck squamous cell carcinoma.
PMID 18258377·Int J Radiat Oncol Biol Phys·2008
8-other
Identifying and targeting hypoxia in head and neck cancer: a brief overview of current approaches.
PMID 17848296·Int J Radiat Oncol Biol Phys·2007
8-other
Distribution dynamics of the Tnt1 retrotransposon in tobacco.
PMID 17786479·Mol Genet Genomics·2007
8-other
Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas.
PMID 17707270·Int J Radiat Oncol Biol Phys·2007
8-other
Nasopharyngeal and oropharyngeal carcinomas: target delineation, therapy delivery and stereotactic boost procedures with intensity-modulated/ image-guided radiation therapy.
PMID 17641511·Front Radiat Ther Oncol·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 14221 EUCLID ST STE H
GARDEN GROVE, CA 92843 - Phone
- (714) 539-9999
Quick Facts
- NPI
- 1609179076
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile